Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
In late 2023, tirzepatide (Mounjaro) surpassed dulaglutide (Trulicity) as the second most commonly prescribed ADM
Quick Answer: Most patients see blood glucose improvements within 14 weeks of starting GLP-1 therapy, while noticeable weight loss typically becomes apparent after 46 weeks, with peak effects at 6072 weeks
So what do we know from the anecdata
Liu X, Zhang Z, Song Y, et al
While the thigh is a common area for intramuscular injections, you can also inject subcutaneously if you have enough fat there
The TRANSCEND-T2D-1 trial (NCT06354660) demonstrated HbA1c reductions of 1.7-2.0% and 36.6 lbs mean weight loss in type 2 diabetes participants over 40 weeks
US$ 26.77
US$ 22.85
US$ 28.90
US$ 25.03
US$ 20.24
US$ 20.35
